BrainStorm Cell Therapeutics Submits Special Protocol Assess

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

Related Keywords

California , United States , Lisa Guiterman , Stacy Lindborg , Chaim Lebovits , Prnewswire Brainstorm Cell Therapeutics Inc , Brainstorm Cell Therapeutics Inc , European Medicines Agency , California Institute For Regenerative Medicine , National Ms Society , Nasdaq , Drug Administration , Storm Cell Therapeutics , Special Protocol Assessment , Chief Executive Officer , Protocol Assessment , Floor Effect , Orphan Drug , California Institute , Regenerative Medicine , Regarding Forward Looking Statements , Health Care Amp Hospitals , Otc , Mallcap , Medical Pharmaceuticals , Biotechnology , Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,